Dr. C. Anand Narayan, MBBS.,MD(RT).,NFPM.,
He completed his MBBS from Government Stanley Medical College, Chennai, and went on to earn his MD in Radiation Oncology from Sawai Man Singh Medical College, Jaipur. He further specialized in advanced radiation techniques through a two-year clinical fellowship in IMRT / IGRT at the renowned Tata Memorial Hospital, Mumbai. He has completed his Palliative Medicine fellowship from Indian Institute of Palliative Medicine. He had been actively involved in teaching DNB Radiation Oncology students for the past 10 years and has served as a thesis guide for several of them. He also contributes to academic sessions conducted by the National Board of Examinations in Medical Sciences (NBEMS), delivering lectures and engaging in academic activities aimed at postgraduate training.
Dr. C. Anand Narayan,
MBBS.,MD(RT).,NFPM.,
He has over 15 years of experience in the field of Radiation Oncology. From 2012 to 2025, he served as Consultant Radiation Oncologist and Chief of Radiation Oncology at GKNM Hospital, Coimbatore. During his tenure, he played a pivotal role in establishing and advancing precision radiotherapy services. He has extensive expertise in treating a wide range of cancers using advanced techniques such as IMRT, IGRT, and other image-guided modalities, with a strong focus on delivering effective and patient-centered cancer care.
Breast Cancer Prostate Cancer Gastrointestinal Cancers Sarcoma Stereotactic Radiotherapy Cancer Survivorship
Association of Radiation Oncologists of India (AROI) Indian College of Radiation Oncologists (ICRO) GastroIntestinal Oncology Society (GIOS)
Multi-Institutional Clinical Outcomes of Biopsy Gleason Grade Group 5 Prostate Cancers Treated With Contemporary High-Dose Radiation and Long-Term Androgen Deprivation Therapy. Clin Oncol (R Coll Radiol) 2023 Jul;35(7):454-462. Prostate Specific Membrane Antigen Avid Thyroid Cancer in Patients with Prostate Cancer: A Report of Two Cases. Journal of Case Reports 2023;13 (4), 114-117. Fatal Spontaneous Tumor Lysis Syndrome: A Rare Presentation in Sarcomatoid Carcinoma. Journal of Case Reports 2023; 13 (1), 15-18. Predictors of Grade 3 or Higher Late Bowel Toxicity in Patients Undergoing Pelvic Radiation for Cervical Cancer: Results From a Prospective Study. Int J Radiat Oncol Biol Phys 2014; 88(3):630-5. Evaluation of Interrater and Interscale agreement in assessing late bowel toxicity after pelvic radiation in patients with carcinoma cervix. Jpn J Clin Oncol 2013; 43(5):508-514. Image guided radiation therapy (IGRT): Physician’s perspective- J Med Phys 2012;37(4): 174–182.
He is a regular invited faculty in State and National Radiation Oncology conferences.